Health
Mefloquine shows potential as anti-SARS-CoV-2 drug – News-Medical.Net
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome…
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specifically, mefloquine has been shown to prevent the entry of SARS-CoV-2 into host cells and reduce the viral loadin vitro. The study is currently available on the bioRxiv* preprint server.
The recent pandemic of coronavirus disease 2019 (COVID-19) has put a substantial amount of burden on healthcare…
-
Noosa News24 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
Noosa News22 hours agoEaster weather forecast: What to expect in Sydney, Perth, Melbourne, Brisbane, Adelaide and Canberra
-
Noosa News22 hours agoQueensland cop cleared by court of stealing watches during anti-gang raid
-
Noosa News23 hours agoAnother power station confirmed offline as political fallout continues amid cultural issues